SCHEMBL30797057

SCHEMBL30797057

Cc1n[nH]cc1N1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ SMARCA2 P51531 1/20 0.45
▸ SMARCA4 P51532 1/20 0.45
▸ PBRM1 Q86U86 1/20 0.45
▸ CKS1B P61024 1/20 0.44
▸ SKP1 P63208 1/20 0.44
▸ SKP2 Q13309 1/20 0.44
▸ GPR119 Q8TDV5 4/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ TSHR P16473 1/20 0.44
▸ ACHE P22303 1/20 0.43
▸ SMPD3 Q9NY59 1/20 0.43
▸ MAP4K4 O95819 1/20 0.43
▸ USP2 O75604 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3570024 0.79 CKS1B (0.61) MAPTALDH1A1LMNASMARCA2SMARCA4
Ammonia Solution, Strong SCHEMBL3561132 0.78 CKS1B (0.60) MAPTALDH1A1SMARCA2SMARCA4PBRM1
SCHEMBL26669459 0.77 MAPT (0.47) MAPTALDH1A1LMNASMARCA2SMARCA4
SCHEMBL14686997 0.76 SMPD3 (0.49) MAPTALDH1A1LMNASMARCA2SMARCA4
SCHEMBL25193207 0.76 MAPT (0.52) MAPTALDH1A1LMNACKS1BSKP1
SCHEMBL3565243 0.76 GPR119 (0.51) SMARCA2SMARCA4PBRM1CKS1BSKP1
SCHEMBL17236188 0.75 MAPT (0.54) MAPTALDH1A1LMNASMARCA2SMARCA4
SCHEMBL10317314 0.75 POLB (0.58) MAPTALDH1A1LMNASMARCA2SMARCA4
SCHEMBL31465821 0.75 RET (0.49) MAPTALDH1A1LMNASMARCA2SMARCA4
SCHEMBL31210727 0.75 KCNH2 (0.45) MAPTALDH1A1LMNASMARCA2SMARCA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4539849-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 Therapeutics, Inc. (US) 2025-04-23 — — EP disclosed
WO-2023244764-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 THERAPEUTICS, INC. (US) 2023-12-21 — — WO disclosed
Send feedback